Physician profile
Altaf Karim
NPI 1063509008
$519.45
in general payments reported to CMS, 2019-2025
18 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $59.51 · 2021: $35.39 · 2022: $27.56 · 2023: $61.94 · 2024: $37.80 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $240.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $109.66 | 2022-2025 | |
| Boston Scientific Corporation | $79.73 | 2020-2021 | |
| Novo Nordisk INC | $31.84 | 2019-2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $28.31 | 2022-2023 | Mounjaro |
| Astellas Pharma US INC | $27.80 | 2019 | |
| Shire North American Group INC | $27.64 | 2019 | |
| Hologic Sales and Service, LLC | $23.36 | 2025 | Thinprep 2000 Processor |
| Ironshore Pharmaceuticals INC. | $21.62 | 2019 | |
| Dynavax Technologies Corporation | $21.46 | 2025 | Heplisav-B |
| Amgen INC. | $21.35 | 2024 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.31 | 2019 | |
| Corcept Therapeutics | $17.73 | 2025 | Korlym |
| Si-Bone, INC. | $17.11 | 2019 | |
| Abbott Laboratories | $16.73 | 2023 | Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $15.17 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $14.47 | 2019 | |
| Dexcom, INC. | $14.15 | 2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Altaf Karim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.